MP
Mark Purcell Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$115B
| $47.09 | $58 |
23%
upside
| Overweight |
8 Sep ‘25
4 days ago |
|
2
Novartis
NVS
$240B
| $123.87 | $114 |
8%
downside
| Equal-Weight |
23 Jan ‘24
1 year ago |
|
3
GSK
GSK
$82.1B
| $40.77 | $44 |
8%
upside
| Equal-Weight |
23 Jan ‘24
1 year ago |
|
4
AstraZeneca
AZN
$246B
| $79.47 | $85 |
7%
upside
| Overweight |
23 Jan ‘24
1 year ago |
|
5
Novo Nordisk
NVO
$244B
| $54.92 | $120 |
119%
upside
| Overweight |
23 Jan ‘24
1 year ago |
|